Supplementary Table S1 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer

<p>Summarized metrics for WES data</p>

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριος συγγραφέας: Emil Christensen (15054394) (author)
Άλλοι συγγραφείς: Iver Nordentoft (15054397) (author), Karin Birkenkamp-Demtröder (15054400) (author), Sara K. Elbæk (15054403) (author), Sia V. Lindskrog (15054406) (author), Ann Taber (15054409) (author), Tine G. Andreasen (15054412) (author), Trine Strandgaard (15054415) (author), Michael Knudsen (15054418) (author), Philippe Lamy (15054421) (author), Mads Agerbæk (15054424) (author), Jørgen B. Jensen (15054427) (author), Lars Dyrskjøt (15054430) (author)
Έκδοση: 2025
Θέματα:
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
_version_ 1849927633228267520
author Emil Christensen (15054394)
author2 Iver Nordentoft (15054397)
Karin Birkenkamp-Demtröder (15054400)
Sara K. Elbæk (15054403)
Sia V. Lindskrog (15054406)
Ann Taber (15054409)
Tine G. Andreasen (15054412)
Trine Strandgaard (15054415)
Michael Knudsen (15054418)
Philippe Lamy (15054421)
Mads Agerbæk (15054424)
Jørgen B. Jensen (15054427)
Lars Dyrskjøt (15054430)
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author_facet Emil Christensen (15054394)
Iver Nordentoft (15054397)
Karin Birkenkamp-Demtröder (15054400)
Sara K. Elbæk (15054403)
Sia V. Lindskrog (15054406)
Ann Taber (15054409)
Tine G. Andreasen (15054412)
Trine Strandgaard (15054415)
Michael Knudsen (15054418)
Philippe Lamy (15054421)
Mads Agerbæk (15054424)
Jørgen B. Jensen (15054427)
Lars Dyrskjøt (15054430)
author_role author
dc.creator.none.fl_str_mv Emil Christensen (15054394)
Iver Nordentoft (15054397)
Karin Birkenkamp-Demtröder (15054400)
Sara K. Elbæk (15054403)
Sia V. Lindskrog (15054406)
Ann Taber (15054409)
Tine G. Andreasen (15054412)
Trine Strandgaard (15054415)
Michael Knudsen (15054418)
Philippe Lamy (15054421)
Mads Agerbæk (15054424)
Jørgen B. Jensen (15054427)
Lars Dyrskjøt (15054430)
dc.date.none.fl_str_mv 2025-11-25T13:08:27Z
dc.identifier.none.fl_str_mv 10.1158/1078-0432.30707707
dc.relation.none.fl_str_mv https://figshare.com/articles/dataset/Supplementary_Table_S1_from_Cell-Free_Urine_and_Plasma_DNA_Mutational_Analysis_Predicts_Neoadjuvant_Chemotherapy_Response_and_Outcome_in_Patients_with_Muscle-Invasive_Bladder_Cancer/30707707
dc.rights.none.fl_str_mv CC BY
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Cancer
Cancer Detection and Diagnosis
Therapeutic Research and Development
Methods and Technology
Biomarkers
Prognostic biomarkers
Genitourinary Cancers
Bladder cancer
Liquid Biopsy
Translational Research
dc.title.none.fl_str_mv Supplementary Table S1 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
dc.type.none.fl_str_mv Dataset
info:eu-repo/semantics/publishedVersion
dataset
description <p>Summarized metrics for WES data</p>
eu_rights_str_mv openAccess
id Manara_c78f3ec71c46f17cf62e0c85145b12ab
identifier_str_mv 10.1158/1078-0432.30707707
network_acronym_str Manara
network_name_str ManaraRepo
oai_identifier_str oai:figshare.com:article/30707707
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY
spelling Supplementary Table S1 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder CancerEmil Christensen (15054394)Iver Nordentoft (15054397)Karin Birkenkamp-Demtröder (15054400)Sara K. Elbæk (15054403)Sia V. Lindskrog (15054406)Ann Taber (15054409)Tine G. Andreasen (15054412)Trine Strandgaard (15054415)Michael Knudsen (15054418)Philippe Lamy (15054421)Mads Agerbæk (15054424)Jørgen B. Jensen (15054427)Lars Dyrskjøt (15054430)CancerCancer Detection and DiagnosisTherapeutic Research and DevelopmentMethods and TechnologyBiomarkersPrognostic biomarkersGenitourinary CancersBladder cancerLiquid BiopsyTranslational Research<p>Summarized metrics for WES data</p>2025-11-25T13:08:27ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/1078-0432.30707707https://figshare.com/articles/dataset/Supplementary_Table_S1_from_Cell-Free_Urine_and_Plasma_DNA_Mutational_Analysis_Predicts_Neoadjuvant_Chemotherapy_Response_and_Outcome_in_Patients_with_Muscle-Invasive_Bladder_Cancer/30707707CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307077072025-11-25T13:08:27Z
spellingShingle Supplementary Table S1 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
Emil Christensen (15054394)
Cancer
Cancer Detection and Diagnosis
Therapeutic Research and Development
Methods and Technology
Biomarkers
Prognostic biomarkers
Genitourinary Cancers
Bladder cancer
Liquid Biopsy
Translational Research
status_str publishedVersion
title Supplementary Table S1 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
title_full Supplementary Table S1 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
title_fullStr Supplementary Table S1 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
title_full_unstemmed Supplementary Table S1 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
title_short Supplementary Table S1 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
title_sort Supplementary Table S1 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
topic Cancer
Cancer Detection and Diagnosis
Therapeutic Research and Development
Methods and Technology
Biomarkers
Prognostic biomarkers
Genitourinary Cancers
Bladder cancer
Liquid Biopsy
Translational Research